TRANE TECHNOLOGIES PLC (TT) valuation

Share price $416.74 · As of last filing 2026-03-31

Price-to-Earnings

P/E · Trailing Diluted
32.21×
P/E history →

Price-to-Free-Cash-Flow

P/FCF · Trailing
29.36×
P/FCF history →

Free-Cash-Flow Yield

FCF Yield · Trailing
3.41%
FCF Yield history →

Enterprise-Value-to-EBITDA

EV/EBITDA · Trailing
22.32×
EV/EBITDA history →

Price-to-Sales

P/S · Trailing
4.26×
P/S history →

Price-to-Book

P/B · Latest filing
10.72×
P/B history →

Earning Power Value & reverse-DCF

Not investment advice. Both models below are mechanical algorithms — they don't account for any business-, industry-, or situation-specific context (management changes, regulatory shifts, segment mix, accounting one-offs beyond what XBRL tagging captures, etc.). Neither number is a forecast, a price target, or a suggestion to buy or sell any stock. They are starting points for further analysis, not conclusions.
A note on share counts — three different denominators in play
XBRL exposes three different share figures, and each is the right denominator for a different question:
  • Weighted-average diluted — the filed P/E denominator (NetIncome ÷ this = diluted EPS). Used on the P/E card above because EPS is pulled directly from the EarningsPerShareDiluted XBRL tag and is locked to that share count.
  • Point-in-time CSO (latest CommonStockSharesOutstanding) — matches a point-in-time price for market-cap-based multiples (P/S, P/B, EV/EBITDA, P/FCF, FCF Yield) and the WACC equity weight. Cards labelled "shares outstanding" use this.
  • TSM-scaled diluted — point-in-time CSO scaled by the latest filer-disclosed (WeightedAverageDiluted ÷ WeightedAverageBasic) ratio. Estimates today's fully-diluted share count and is the denominator for the EPV per share and the reverse-DCF equity bridge below.
The three counts drift apart for high-buyback filers; the methodology diluted-shares note walks through which one fits which context and why.

Earning Power Value

Bruce Greenwald's no-growth fair-value floor: capitalise after-tax operating earnings (NOPAT) at the cost of capital (WACC), then bridge to equity (+ excess cash, − total debt, − minority interest). Assumes today's earnings approximate steady-state earnings power and ignores any growth premium. See the EPV methodology for assumptions and caveats.

Adjusted (less growth CapEx) matches the normalized variant for this filer — max(0, TTM CapEx $343.8M − TTM D&A $378.3M) = $0 (D&A exceeds CapEx, so the maintenance-CapEx ≈ D&A heuristic doesn't subtract anything). The trail's step 4 walks through the floor.

EPV per share
$73.80
vs share price $416.74
−82.3%
Trimmed FY-history median margin
11.87%
× Revenue (3-yr FY median)
$19.84B
= Normalized EBIT
$2.35B
× (1 − tax)
0.7900
= NOPAT
$1.86B
÷ WACC
9.13%
= Enterprise EPV
$20.37B
+ Excess cash
$0
− Total debt
$3.92B
− Minority interest
$21.6M
= Equity EPV
$16.43B
÷ Diluted shares
222.6M

EPV full calculation trail Click to expand — every number above derived step by step.

1 · Starting EBIT (TTM)

GAAP operating income from the trailing-twelve-month window ending 2026-03-31 (10-Q anchor — values reconstructed from quarterly facts). Concept: us-gaap: OperatingIncomeLoss


Method: Sum of the four most recent per-quarter values
  Q1 FY26 (2026-03-31): $776.1M
  Q4 FY25 (2025-12-31): $819.0M
  Q3 FY25 (2025-09-30): $1.17B
  Q2 FY25 (2025-06-30): $1.16B
= TTM EBIT = $3.92B
                  

2 · Tax rate derivation

Source: 3-year median of EffectiveTaxRate. See the tax-rate methodology for the full precedence ladder (3-yr median → 2-yr mean → latest FY → REIT-zero → US-statutory default).

Tax rate = 21.0%
                

3 · Normalized NOPAT

Greenwald's textbook EPV normalises both inputs so a single cyclical or one-time-charge year doesn't whipsaw the floor. Margin anchor: when the filer has at least 8 years of FY EBIT-margin history, the 10-90% trimmed median of every FY observation is preferred — it drops the top and bottom decile so a single boom (COVID supply shock, regulatory one-off) or bust year doesn't anchor the floor. Filers with thinner history fall back to the 3-yr FY mean. Revenue follows a backward-looking ladder: 3-yr FY median → 2-yr FY mean → 1-yr FY → TTM fallback. Analyst forecasts are intentionally excluded — the reverse-DCF below is where forward numbers live, except on filers where the TTM EBIT window carried a material whole-segment disposition gain (the FY revenue base then pre-dates the divestiture and overstates the go-forward business — analyst forward FY consensus is preferred, with TTM as a last fallback). The symmetric case fires for partial-period acquisitions: when an FY in the sampled window carries a filer-disclosed pro-forma revenue tag (BusinessAcquisitionsProFormaRevenue) materially higher than reported, the pro-forma value substitutes into the median/mean so the anchor reflects full-period ownership of the acquired entity. See the EPV methodology for the full recipe.


Trimmed FY-history median EBIT margin = 11.87%  (15 of 19 FY observations after 10-90% trim; raw 3-yr mean 17.54%, 3-yr range [16.37%, 18.61%])
TTM EBIT margin      = 18.17%

3-yr FY revenue history:
  FY2025 = $21.32B
  FY2024 = $19.84B   ← median
  FY2023 = $17.68B
Revenue (3-yr FY median) = $19.84B (FY2024)

Normalized EBIT = trimmed FY-history p50 margin × normalisation revenue
                = 11.87% × $19.84B
                = $2.35B

NOPAT = Normalized EBIT × (1 − tax rate)
      = $2.35B × 0.7900
      = $1.86B
                        

4 · Growth CapEx (capex-adjusted variant)

Greenwald's maintenance-CapEx ≈ D&A heuristic. Floored at zero so a filer with CapEx < D&A doesn't get a "negative growth CapEx" bonus added back to NOPAT — that excess D&A is already-paid wear, not earnings. See the EPV methodology .


TTM CapEx — Prior FY + current-quarter YTD − same-quarter-prior-year YTD
  FY FY25 (2025-12-31): +$383.0M
  Q1 FY26 (2026-03-31) YTD: +$79.7M
  Q1 FY25 (2025-03-31) YTD: −$118.9M
= $343.8M
                      

TTM D&A — Prior FY + current-quarter YTD − same-quarter-prior-year YTD
  FY FY25 (2025-12-31): +$376.3M
  Q1 FY26 (2026-03-31) YTD: +$101.1M
  Q1 FY25 (2025-03-31) YTD: −$99.1M
= $378.3M
                      

TTM SBC — Prior FY + current-quarter YTD − same-quarter-prior-year YTD
  FY FY25 (2025-12-31): +$86.6M
  Q1 FY26 (2026-03-31) YTD: +$26.8M
  Q1 FY25 (2025-03-31) YTD: −$22.2M
= $91.2M
                      
Growth CapEx = max(0, TTM CapEx − TTM D&A)
             = max(0, $343.8M − $378.3M)
             = $0

Adjusted NOPAT = Normalized NOPAT − Growth CapEx
              = $1.86B − $0
              = $1.86B
                    

5 · Capitalisation rate (WACC)

Same WACC the reverse-DCF below uses — capital-asset pricing model for cost of equity, synthetic-rating credit spread for cost of debt, market weights from the equity bridge inputs. See the WACC methodology and the full WACC trail under section 4 of the reverse-DCF below.

Cost of equity = Rf + β × ERP
               = 4.3% + 1.12 × 4.5%
               = 9.4%
Cost of debt   = 3.9% (after-tax, synthetic AAA)
Weights        = E/V 95.9%, D/V 4.1%
WACC           = 9.1%
                    

6 · Enterprise EPV

Enterprise EPV (normalized) = NOPAT ÷ WACC
                            = $1.86B ÷ 9.1%
                            = $20.37B

Enterprise EPV (adjusted)   = (NOPAT − Growth CapEx) ÷ WACC
                            = $1.86B ÷ 9.1%
                            = $20.37B
                

7 · Equity bridge

Same balance-sheet adjustments as the reverse-DCF: add the excess (non-operating) cash an acquirer would pocket at close, subtract the debt that has senior claim on enterprise value, and subtract the noncontrolling interest in consolidated subsidiaries that doesn't accrue to common shareholders. See the balance-sheet aggregates methodology for the exact concept chains.

Enterprise EPV   = $20.37B
+ Excess cash    = $0
− Total debt     = $3.92B
− NCI            = $21.6M   (book value of MinorityInterest $21.6M)
= Equity EPV     = $16.43B

Adjusted Equity EPV = $20.37B + $0 − $3.92B − $21.6M
                    = $16.43B
                

8 · Per share & vs market price

Diluted shares         = 222.6M
EPV / share (normalized) = 16.43B ÷ 222.6M shares
                       = $73.80
EPV / share (adj.)     = $73.80

Market price           = $416.74
Premium vs price       = (EPV/share − market) ÷ market
                       = −82.3%   (normalized), −82.3%   (adjusted)
                

Open this EPV in the calculator → Open EPV with 3-yr mean CapEx →
Every input above is pre-filled; the calculator auto-runs and lets you override any assumption.

Expectations investing: what does the price imply?

Growth stretched +8pp above source
Implied margin assumes zero reinvestment (CapEx ≤ D&A) — the solver only flexes margin, not reinvestment. TTM CapEx is below TTM D&A so the s2c ladder pins reinvestment-of-revenue at 0 across the explicit window. With reinvestment fixed, the only knob the solver can turn is target EBIT margin — the implied margin reads market expectations conditional on zero reinvestment, not as a pure margin judgement. If reinvestment turns positive (M&A absorption, capacity build), the same EV target reconciles with a higher margin path.
Alternative framing — margin held flat. If margin stayed at TTM 18.2% across the full 10-year horizon (same growth path, same reinvestment policy), fair value would be $353.90 per share (-15.1% vs the $416.74 market price). The gap of -$58.29 per share is the dollar magnitude of the implied margin compression the price-solved scenario above attributes to the margin axis — the second solver knob the model can't turn while reinvestment is held by the s2c ladder.

Rappaport-style reverse-DCF. We start from the current market price ($416.74 × 222.6M shares = $92.75B market cap, $96.69B enterprise value) and solve for the operating path that would justify it.

To reconcile today's price with a plausible scenario, the model lands on:

  • Year-1 revenue growth: 16.2%
    Source is analyst consensus (absolute forecast, TTM-anchored) of 8.2%; the scenario bumped Y1 by +8.0pp to reconcile.
  • Target EBIT margin (Y10): 21.8%
    Scenario lands above the 3-yr max of 18.6% (starting 18.2%, ending 21.8%).
  • High-growth plateau: 3 years
    Tier default for Y2 at 8.4%.

at or below the reference above the reference outside the historical band

Where the PV comes from
Y1–3
+12%
Y4–10
+35%
Terminal
+53%

Share of the total PV the model has assigned to each window. The further out a cash flow sits, the harder it is to estimate — so readers can weigh how much of the scenario rests on the near, plateau, and post-horizon periods.


Facts · TTM as of 2026-03-31 (Q12026)

Share price
$416.74
Diluted shares
222.6M
Total debt
$3.92B
Cash & equivalents
$0
Noncontrolling interest
$21.6M
Revenue
$21.60B
EBIT (GAAP)
$3.92B
EBIT margin (GAAP)
18.2%
Operating cash flow
$3.48B
CapEx
$343.8M
Observed YoY growth
6.4%
Analyst current-FY growth
9.6%
Analyst next-FY growth
8.5%
3-year revenue CAGR
10.5%

Assumptions

Initial revenue growth
8.2%
Year-2 growth
8.4%
Starting EBIT margin
18.2%
Tax rate
19.4% → 21.0%
WACC
9.1%
Starting ROIC
25.3%

Constants

Horizon
10 years
Terminal growth
2.5%
Terminal ROIC
9.1%
Discounting
Mid-year

See the discounting convention, plateau tier rules, and the terminal ROIC fade on the methodology page.


Year-by-year reconciliation

Not a forecast. These are the year-by-year revenue, margin, and cash-flow figures the reverse-DCF solver had to assume for its present value to land on today's enterprise value — the operating path the market price is pricing in, not a view of what the company will deliver.

Year Revenue Growth EBIT Margin NOPAT ROIC Reinvestment FCF Discount PV of FCF
1 $25.10B 16.2% $4.65B 18.5% $3.74B 23.7% $0 $3.74B 0.957 $3.58B
2 $29.23B 16.4% $5.52B 18.9% $4.44B 22.1% $0 $4.44B 0.877 $3.89B
3 $34.04B 16.4% $6.56B 19.3% $5.25B 20.4% $0 $5.25B 0.804 $4.22B
4 $38.96B 14.5% $7.64B 19.6% $6.11B 18.8% $0 $6.11B 0.737 $4.50B
5 $43.82B 12.5% $8.76B 20.0% $6.99B 17.2% $0 $6.99B 0.675 $4.72B
6 $48.40B 10.5% $9.85B 20.3% $7.84B 15.6% $0 $7.84B 0.618 $4.85B
7 $52.51B 8.5% $10.87B 20.7% $8.64B 14.0% $0 $8.64B 0.567 $4.90B
8 $55.91B 6.5% $11.78B 21.1% $9.35B 12.4% $0 $9.35B 0.519 $4.85B
9 $58.42B 4.5% $12.52B 21.4% $9.91B 10.7% $0 $9.91B 0.476 $4.72B
10 $59.88B 2.5% $13.05B 21.8% $10.31B 9.1% $0 $10.31B 0.436 $4.50B
Sum of PV of FCF (years 1-10) $44.74B

Terminal value

NOPATN+1
$10.57B
ReinvestmentN+1
$2.82B
FCFN+1
$7.75B
Terminal value (undiscounted)
$116.84B
PV of terminal value
$50.94B
Gordon-growth: TV = FCFN+1 ÷ (WACC − g) = $7.75B ÷ (9.1% − 2.5%).

Equity bridge

PV of operating FCF $44.74B
+ PV of terminal value $50.94B
= Enterprise value $95.68B
− Total debt $3.92B
+ Cash & equivalents $0
− Noncontrolling interest $21.6M
= Equity value $91.73B
÷ Diluted shares 222.6M
= DCF PV / share $412.19
Market price $416.74
Reconciliation delta −1.1% (≈ 0 by construction)

Full calculation trail Click to expand — every number on this page derived step by step.

0 · TTM reconstruction (anchor: Q12026, 2026-03-31)

The latest filing is a 10-Q, so "base year" revenue / EBIT / OCF / CapEx are reconstructed as trailing-twelve-month values. Per-quarter facts (typical for income-statement items) get summed across four quarters; YTD-cumulative facts (typical for cash-flow items) use prior FY + YTDnow − YTDprior year same quarter.

Revenue
Sum of the four most recent per-quarter values
  • Q1 FY26 (2026-03-31): $4.97B
  • Q4 FY25 (2025-12-31): $5.14B
  • Q3 FY25 (2025-09-30): $5.74B
  • Q2 FY25 (2025-06-30): $5.75B
  • = $21.60B
EBIT
Sum of the four most recent per-quarter values
  • Q1 FY26 (2026-03-31): $776.1M
  • Q4 FY25 (2025-12-31): $819.0M
  • Q3 FY25 (2025-09-30): $1.17B
  • Q2 FY25 (2025-06-30): $1.16B
  • = $3.92B
OCF
Prior FY + current-quarter YTD − same-quarter-prior-year YTD
  • FY FY25 (2025-12-31): +$3.19B
  • Q1 FY26 (2026-03-31) YTD: +$626.2M
  • Q1 FY25 (2025-03-31) YTD: −$339.5M
  • = $3.48B
CapEx
Prior FY + current-quarter YTD − same-quarter-prior-year YTD
  • FY FY25 (2025-12-31): +$383.0M
  • Q1 FY26 (2026-03-31) YTD: +$79.7M
  • Q1 FY25 (2025-03-31) YTD: −$118.9M
  • = $343.8M
Stock-based compensation
Prior FY + current-quarter YTD − same-quarter-prior-year YTD
  • FY FY25 (2025-12-31): +$86.6M
  • Q1 FY26 (2026-03-31) YTD: +$26.8M
  • Q1 FY25 (2025-03-31) YTD: −$22.2M
  • = $91.2M
Prior-year TTM revenue (growth-calc baseline)
Sum of the four most recent per-quarter values
  • Q1 FY25 (2025-03-31): $4.69B
  • Q4 FY24 (2024-12-31): $4.87B
  • Q3 FY24 (2024-09-30): $5.44B
  • Q2 FY24 (2024-06-30): $5.31B
  • = $20.31B

1 · Enterprise-value target (what the DCF must match)

Diluted shares = point-in-time basic × 1.0068× (filer's TSM dilution multiplier from WeightedAverageNumberOfDilutedSharesOutstanding ÷ WeightedAverageNumberOfSharesOutstandingBasic , period ending 2026-03-31 ). See the diluted-shares methodology.

Total debt $3.92B bundles:
  • Long-term debt (current + noncurrent) $3.92B LongTermDebtCurrent + LongTermDebtNoncurrent
Operating- and finance-lease liabilities and any tagged underfunded pension obligation are folded into total debt as Damodaran-style debt-equivalents on top of the financial-debt concepts; see the total-debt methodology.

Noncontrolling interest = book NCI on the consolidated BS ( MinorityInterest $21.6M ). Subtracted from the equity bridge so per-share fair value reflects the common-shareholder claim only. See the NCI methodology.

Market cap     = price × diluted shares
               = $416.74 × 222.6M
               = $92.75B

EV target      = market cap + total debt + NCI − cash & equivalents
               = $92.75B + $3.92B + $21.6M − $0
               = $96.69B
            

2 · Starting NOPAT (base year 0)

Tax rate source: 3-year median of EffectiveTaxRate. See the tax-rate methodology for the precedence ladder.

Tax rate fades from 19.4% at year 0 to 21.0% at year 10 (US federal statutory floor). The current effective rate is the most honest reading of this filer's recent economics, but holding it as the perpetuity rate would compound a one-off NOL benefit / R&D credit / foreign-mix tilt across the whole horizon. WACC's after-tax cost of debt uses the terminal rate so the discount rate is consistent with the long-run cash flows it discounts.

GAAP EBIT          = $3.92B   (18.2% of revenue)
× (1 − tax rate)  = × (1 − 19.4%) = × 0.8064
= NOPAT₀            = $3.16B
            

3 · Invested capital & starting ROIC

Invested capital = total debt + book equity − cash
                 = $3.92B + $8.59B − $0
                 = $12.51B

Raw ROIC₀        = NOPAT₀ / Invested capital
                 = $3.16B / $12.51B
                 = 25.3%
(no cap applied; raw value is within the 40.0% ceiling)
            

4 · WACC derivation

Cost of equity from CAPM , after-tax cost of debt from a synthetic credit rating built off interest coverage , weighted by market values of equity and debt. Inputs: Rf is FRED DGS10's 90-day mean (latest 2026-05-29); β is the 5-yr weekly regression vs VOO, floored at 1.00 for the cost-of-equity step (the empirical security market line is much flatter than CAPM predicts — Frazzini-Pedersen 2014, "Betting Against Beta" — so unfloored CAPM systematically under-estimates required return for low-β filers); ERP is the latest Damodaran US total ERP (2026-01-01). The synthetic rating is a Damodaran coverage-table heuristic, not an empirical S&P / Moody's letter. It maps EBIT-÷-interest into a letter-grade bucket and reads the spread out of a lookup table; an actual agency rating considers qualitative factors (governance, market position, jurisdiction, off-balance-sheet exposure) the coverage ratio can't capture. For most filers the gap is small; for capital-light, high-coverage names — software, IT services, consumer brands — this method tends to print AAA/AA where actual agency ratings sit at A/BBB+, and the resulting cost of debt is a few tens of bps light. WACC is more sensitive to β and weights than to credit, so the headline barely moves; flagged here so readers don't read the rating as an empirical agency assessment.

Cost of equity        = Rf + β × ERP
                      = 4.3% + 1.12 × 4.5%
                      = 9.4%

Cost of debt (pretax) = Rf + credit spread
                      = 4.3% + 0.6%   (synthetic AAA, EBIT ÷ interest = 17.5×)
                      = 4.9%
× (1 − tax rate)      = × (1 − 19.4%)
= Cost of debt (a/t)  = 3.9%

Weights               E/V = 95.9%, D/V = 4.1%

WACC (raw)            = E/V × cost_e + D/V × cost_d_after_tax
                      = 95.9% × 9.4% + 4.1% × 3.9%
                      = 9.1%
                

5 · Growth path construction


Source       = analyst consensus (absolute forecast, TTM-anchored): Y1 = 8.2%, Y2 = 8.4%

Detailed derivation:
  Current-FY analyst avg revenue forecast = $23.38B   (FY-over-FY vs FY2025 actual = 9.6%)
  Next-FY analyst avg revenue forecast    = $25.35B   (FY-over-FY vs current-FY forecast = 8.4%)
  Base revenue (TTM) = $21.60B
  Latest completed FY revenue (FY2025) = $21.32B   (denominator for the FY-over-FY check above)

  Y1 = current-FY forecast / TTM base revenue − 1
     = $23.38B / $21.60B − 1
     = 8.2%

  Y2 = next-FY forecast / current-FY forecast − 1
     = $25.35B / $23.38B − 1
     = 8.4%

  Note: the absolute analyst forecast is re-anchored
  against TTM (rather than the FY-over-FY consensus
  rate above) because the TTM base spans the current
  FY only partway. Re-anchoring keeps the growth rate
  consistent with the projection's starting revenue
  level.
Clamp        = [2.5%, 60%] (no sub-terminal or 60%+ starts)
Plateau rate = 8.4% (Y2 — held from year 2 through end of plateau)
Tier         = 3 years (rule: plateau rate < 15% → 3y, < 25% → 5y, else 7y)
Plateau      = 3 years
Fade         = linear from effective Y2 to terminal 2.5% across the remaining 7 years

Effective Y1 growth after solver bumps = 16.2%
Effective Y2 growth after solver bumps = 16.4%
Growth by year:
  Y1 = 16.2%
  Y2 = 16.4%
  Y3 = 16.4%
  Y4 = 14.5%
  Y5 = 12.5%
  Y6 = 10.5%
  Y7 = 8.5%
  Y8 = 6.5%
  Y9 = 4.5%
  Y10 = 2.5%
                

6 · Margin path construction

Starting margin (Y0) = 18.2%   (source: TTM EBIT margin (GAAP) — within 4pp of 3-yr mean)
Target margin (Y10)  = 21.8%   (solver output, normal band)
Year-t margin        = starting + (target − starting) × (t / 10)
Margin by year:
  Y1 = 18.5%
  Y2 = 18.9%
  Y3 = 19.3%
  Y4 = 19.6%
  Y5 = 20.0%
  Y6 = 20.3%
  Y7 = 20.7%
  Y8 = 21.1%
  Y9 = 21.4%
  Y10 = 21.8%

Filer-history margin distribution (19 FY, trimmed-10-90):
  p25 = 10.0%, p50 = 11.9%, p75 = 12.5%
  raw min = -19.3%, raw max = 18.6%
Path-stretch sub-counts:
  10 of 10 years above filer p75 (12.5%)
  9 of 10 years above filer max-ever (18.6%)
  Terminal/start ratio = 120%
Binding trigger = unprecedented-margin (drives the page badge)
            

7 · ROIC path construction

The capex heuristic compares latest-period CapEx ($343.8M) against the Normalized CapEx (3-yr mean) of $351.4M — mean of the last three annual CapEx values. When the latest is above 1.4× that mean and CapEx is at least 5% of revenue, we treat the filer as capital-intensive and mid-investment, hold ROIC flat for a 5-year harvest phase, and only then fade to terminal ROIC. The 3-yr mean does not feed the DCF directly — it only gates this flag.

Capex-heuristic inactive (latest CapEx 0.98× the 3-yr mean of $351.4M — below the 1.4× / 5%-of-revenue gates).
Fade from Y1: ROIC_t = ROIC₀ + (ROIC_terminal − ROIC₀) × (t / 10)
ROIC₀ = 25.3%; ROIC_terminal = 9.1%

ROIC by year:
  Y1 = 23.7%
  Y2 = 22.1%
  Y3 = 20.4%
  Y4 = 18.8%
  Y5 = 17.2%
  Y6 = 15.6%
  Y7 = 14.0%
  Y8 = 12.4%
  Y9 = 10.7%
  Y10 = 9.1%
            

7a · Reinvestment formula

The Damodaran growth-firm closure Reinvestment_t = ΔRevenue_t ÷ salesToCapital collapses to noise whenever EITHER the 3-year revenue change OR the 3-year net reinvestment is small relative to the revenue base. The model picks the most-honest formula via a 3-tier ladder: tier-1 standard sales-to-capital fires only when both signals carry magnitude AND the resulting ratio sits inside the typical 0.5–8 band; tier-2 substitutes a TTM (CapEx − D&A) ÷ Revenue ratio applied to each projection year's revenue (not its delta); tier-3 falls through to the ΔNOPAT ÷ ROIC closure when neither signal is usable.

Inputs:
  ΔRev_3y                          = $5.61B
  netReinvest_3y (CapEx − D&A)     = -$49.5M
  avgRevenue_3y                    = $18.80B
  TTM CapEx − D&A                  = -$34.5M
  TTM Revenue                      = $21.60B

Tier-1 gates (all three must clear):
  |ΔRev_3y| / avgRev_3y > 1.0%     29.85%         ✓ pass
  netReinv_3y / avgRev_3y > 1.5%   -0.26%         ✗ fail
  0.5 ≤ s2c candidate ≤ 8          5.322          ✓ pass

Tier-2 fires (gate failed: denominator). Substituting CapEx-of-revenue heuristic.
  capexOfRevenueRatio (raw)        = -0.16% — D&A > CapEx; floored at 0%
  capexOfRevenueRatio (used)       = 0.00%
  Reinvestment_t = Revenue_t × 0.00%
            

8 · Solver iterations

Each row is one configuration in the solver ladder; the "Solved margin" column is the result of bisecting the EBIT margin (up to 80 inner iterations) to match the EV target for that row's plateau / Y1 bump / phase. The solver sweeps Y1 growth bumps 0pp → +20pp across the plateau ladder inside the normal margin bracket, then — if nothing reconciles — repeats the same sweep in a widened margin band ([-10%, 80%]). The first feasible row is the one the page uses. If no combination reconciles, the page shows the row whose PV sits closest to the target EV so both levers are balanced.

# Phase Plateau Y1 bump Solved margin PV(EV) vs target Feasible?
1 normal 3y +0pp 21.8% $65.69B −32.1% no
2 normal 3y +2pp 21.8% $72.25B −25.3% no
3 normal 3y +4pp 21.8% $79.40B −17.9% no
4 normal 3y +6pp 21.8% $87.19B −9.8% no
5 normal 3y +8pp 21.8% $95.68B −1.0% yes ✓

9 · Terminal value derivation

NOPAT_{N+1}         = NOPAT_{10} × (1 + g_terminal)
                    = $10.31B × (1 + 2.5%)
                    = $10.57B

ΔNOPAT              = NOPAT_{N+1} − NOPAT_{10}
                    = $257.8M
Reinvestment_{N+1}  = ΔNOPAT / ROIC_terminal
                    = $257.8M / 9.1%
                    = $2.82B

FCF_{N+1}           = NOPAT_{N+1} − Reinvestment_{N+1}
                    = $10.57B − $2.82B
                    = $7.75B

Terminal value (TV) = FCF_{N+1} / (WACC − g_terminal)
                    = $7.75B / (9.1% − 2.5%)
                    = $116.84B

PV(TV)              = TV / (1 + WACC)^(10 − 0.5)
                    = $116.84B / 2.294
                    = $50.94B

10 · Reconciliation check (DCF PV vs. the market)

This isn't a fair value — it's the inverse check. The solver built the scenario so that DCF PV reproduces the current enterprise value; if the normal bracket worked the delta below is ~0 by construction. A non-zero delta only appears when the solver fell through to the widened margin band.

Σ PV(FCF_1..10) = $44.74B
+ PV(TV)          = $50.94B
= Enterprise value = $95.68B   (≈ EV target $96.69B by construction)
− Total debt      = $3.92B
+ Cash            = $0
− NCI             = $21.6M
= Equity value    = $91.73B
÷ Diluted shares  = 222.6M
= DCF PV / share  = $412.19

Market price      = $416.74
Reconciliation Δ  = −1.1%   (≈ 0 by construction — the solver anchored on this price)
                

Open this scenario in the calculator →
Every input above is pre-filled; the calculator auto-runs and lets you override any assumption.

Every rule above — growth-source priority, plateau tiers, compound cap, solver ladder, flag colours — is documented on the expectations scenario methodology.

What these ratios mean & how they're built: see the valuation ratios glossary on the Financials methodology page — per-ratio definitions and the exact us-gaap concepts behind each numerator and denominator.

Sources. Denominators come from SEC EDGAR XBRL filings for TT (CIK 0001466258); analyst growth forecasts come from analyst consensus. Filing-anchored figures are rendered server-side at the split-adjusted close on the latest reported period-end — so every ratio reconciles to the same filing as every other figure on this page — and the share price, six ratio cards, EPV gap, and reverse-DCF outputs above re-anchor on the most recent daily close in the browser when JavaScript is enabled. The "Full calculation trail" sections stay anchored to the period-end close so the line-by-line arithmetic still reconciles. Per-share denominators are split-adjusted to today's share count.

Related tickers

TSLA

Tesla, Inc.

CRVO

CervoMed Inc.

MDV

MODIV INDUSTRIAL, INC.